NIH-funded research NIH-funded research

How changes in a specific protein affect heart muscle growth and function

Official title: Regulation of STAT3 phosphorylation and its role in orienting myocyte hypertrophy

Funded at Ohio State University · NIH-11101142 · Data updated 2026-11-12

This study is looking at how certain proteins in heart muscle cells can help them grow in a healthy way or cause problems, with the goal of finding new treatments to keep your heart strong and prevent heart failure.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJune 1, 2024
Project endMay 30, 2027
Funding year2025
Award (this year)$249,000
NIH project number5R00HL157684-04
Project IDNIH-11101142 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for heart failure or those with early signs of cardiac hypertrophy.

Less likely to help

Patients with advanced heart failure or those who do not have any cardiac conditions may not benefit from this research.

What this research studies

This research investigates the mechanisms behind heart muscle cell growth, particularly how certain proteins influence whether this growth is beneficial or harmful. By focusing on the phosphorylation of the STAT3 protein, the study aims to understand how heart cells adapt to stress and how this adaptation can prevent heart failure. The approach includes examining cellular responses to stress and testing potential interventions that could help maintain healthy heart function. Patients may benefit from insights that could lead to new treatments for heart conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that prevent heart failure by promoting healthy heart muscle growth.

How similar studies have gone: Other research has shown promise in understanding cardiac hypertrophy, but this specific approach focusing on STAT3 phosphorylation is relatively novel.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Nassal, Drew — Ohio State University
  • Study coordinator: Nassal, Drew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.